Ascorutinum

General characteristics. Structure:

Active agents: ascorbic acid - 0,05 g; rutoside (Rutinum) of-0,05 g

Excipients: sucrose (sugar), potato starch, calcium stearate, talc.

Pharmacological properties:

Ascorbic acid plays an important role in regulation of oxidation-reduction processes, carbohydrate metabolism, coagulability of blood, an angenesis, promotes increase in body resistance. Rutinum eliminates a hyperpermeability of capillaries, strengthens a vascular wall, reducing its puffiness and an inflammation. Possesses antiagregantny action that promotes microcirculation improvement.

Indications to use:

Prevention hypo - and avitaminosis of ascorbic acid and Rutinum.
As a part of complex therapy at a varicosity with edematous and painful syndromes, superficial thrombophlebitis, trophic disturbances and ulcers, at chronic venous insufficiency, at hemorrhagic diathesis.

Route of administration and doses:

Inside on 1 tablet 2-3 times a day in time or after meal. Course of treatment 2-3 weeks.

Features of use:

There are no data.

Side effects:

Allergic reactions (skin rash), dispepsichesky frustration are possible.

Interaction with other medicines:

Ascorbic acid increases absorption of antibiotics of group of penicillin and iron preparations; reduces clinical effect of heparin and indirect anticoagulants.

Contraindications:

The increased individual sensitivity to drug components.

With care
The states which are followed by hypercoagulation of blood and tendency to fibrinferments.

Overdose:

There are no data.

Storage conditions:

In the dry place at a temperature not above 25 °C.
To store in the places unavailable to children.

Issue conditions:

Without recipe

Packaging:

Tablets. On 10 tablets in a blister strip packaging from a film of the polyvinyl chloride and printing aluminum foil varnished. On 50 tablets in banks polymeric complete with covers. Each can or 5 blister strip packagings together with the application instruction are placed in a pack from a cardboard.
It is allowed to place blister strip packagings with the equal number of application instructions in boxes of corrugated fibreboard. Banks polymeric are allowed to be placed in boxes from corrugated fibreboard with department of each row the laying corrugated with the appendix of application instructions in the quantity equal to the number of packagings.